Evidence map›Paper›PMID 34668395›Full record

ArticleJournal of the American Heart Association2021

Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation.

Fareed Moses S Collado, Claudia M Lama von Buchwald, Christina K Anderson, Nidhi Madan, Hussam S Suradi, Henry D Huang, Hani Jneid, Clifford J Kavinsky

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Additional Stroke Risk Factors Beyond the CHAJournal of clinical medicine · 2026
    Article
  8. Article
  9. Article
  10. Quantitative considerations for choosing between Amulet and Watchman FLX and management of device related complications.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Lower-adherence direct oral anticoagulant use is associated with increased risk of thromboembolic events than warfarin.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Fareed Moses S ColladoRush University Medical Center Chicago IL.
Claudia M Lama von BuchwaldRush University Medical Center Chicago IL.
Christina K AndersonRush University Medical Center Chicago IL.ORCID 0000-0002-4190-1687
Nidhi MadanRush University Medical Center Chicago IL.
Hussam S SuradiRush University Medical Center Chicago IL.ORCID 0000-0001-6012-9648
Henry D HuangRush University Medical Center Chicago IL.ORCID 0000-0002-4103-4317
Hani JneidBaylor College of Medicine Houston TX.ORCID 0000-0002-8754-358X
Clifford J KavinskyRush University Medical Center Chicago IL.ORCID 0000-0001-8641-9491
Rush University Medical Center · USBaylor College of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The majority of embolic strokes in patients with nonvalvular atrial fibrillation are caused by thrombi in the left atrial appendage. It is projected that strokes related to atrial fibrillation will markedly increase in the future unless effective mitigation strategies are implemented. Systemic anticoagulation has been known to be highly effective in reducing stroke risk in patients with atrial fibrillation. However, bleeding complications and nonadherence are barriers to effective anticoagulation therapy. Surgical and percutaneous left atrial appendage occlusion devices are nonpharmacologic strategies to mitigate the challenges of drug therapy. We present a contemporary review of left atrial appendage occlusion for stroke prevention in nonvalvular atrial fibrillation. A thorough review of the history of surgical and percutaneous left atrial appendage occlusion devices, recent trials, and US Food and Drug Administration milestones of current left atrial appendage occlusion devices are discussed.

Indexed as

Atrial AppendageAtrial FibrillationStrokeAnticoagulantsHemorrhageHumansAnticoagulantsatrial fibrillationleft atrial appendageleft atrial appendage occlusionstroke

Identifiers

PMID34668395
PMCPMC8751840
OpenAlexW3206222295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.